Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Portola Pharma
3199
Portola Pharma
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Portola (Nasdaq: PTLA) is a biopharma co. focused on developing life-saving therapeutics in thrombosis and hematology. Twitter policy on our site
Suggest edits
Type
B2c
Founded
2003
Raised
$149.1M
Follow us
Also headquartered in Quito
EL MERCIO.
MANDACOB S.A. Factoring Ecuador
Kriptos
Unified Color
ADCstudio
AreaNaranja
YaEsta.com
Krugerlabs
Analytica Investments
Couchy.com
Companies in the same industry
Nevakar
Omeros Corporation
ApoGen Biotechnologies
PvP Biologics
Biscayne Pharmaceuticals, Inc.
Scythian Biosciences
Neumentum, Inc.
Labii Inc.
Prokaryotics
EBD Group
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Acquired by
05 May 2020
Alexion Pharmaceuticals, Inc.
$1,400,000,000
Latest funding
$89,000,000
Venture capital (Series D) - 2011
Temasek Holdings
Eastern Capital
$60,100,000
Venture capital (Series C) - 2009
Adage Capital Management
Advanced Technology Ventures
D.E. Shaw & Co.
+15
Location
Quito
,
United States
Headquarters
Explore Quito
MedCity News
Alexion plunks down $1.4B to acquire Portola Pharmaceuticals
